REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
REATA PHARMACEUTICALS reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
REATA PHARMACEUTICALS reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, three executives at REATA PHARMACEUTICALS received on average a compensation package of $706K, a 77% decrease compared to previous year.
Average pay of disclosed executives at REATA PHARMACEUTICALS
J. Warren Huff, Chief Executive Officer, received $935K in total, which decreased by 82% compared to 2017. 57% of Huff's compensation, or $534K, was in salary. Huff also received $401K in bonus.
Colin J. Meyer, Chief Medical Officer, received a compensation package of $626K, which decreased by 70% compared to previous year. 67% of the compensation package, or $417K, was in salary.
Keith W. Ward, Chief Development Officer, earned $557K in 2018, a 72% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2019.